This chiral compound is a key intermediate in the pharmaceutical industry, primarily used in the synthesis of selective serotonin reuptake inhibitors (SSRIs) such as escitalopram, which are antidepressants and anxiolytics that help regulate mood and alleviate symptoms of depression and anxiety disorders. Its specific (1R,2S) stereochemistry is crucial for the biological activity of the final drugs, making it valuable in chiral synthesis. Derivatives of the parent structure have also been studied for potential applications in treating neuropathic pain via interactions with neurotransmitter systems. Additionally, it is employed in research settings to explore the mechanisms of action of SSRIs and related compounds.